Could Sars-Cov2 affect MS progression?

Arianna Di Stadio; Luigina Romani; Evanthia Bernitsas

doi:10.1016/j.msard.2020.102540

Back

Journal article

Could Sars-Cov2 affect MS progression?

Arianna Di Stadio, Luigina Romani and Evanthia Bernitsas

Multiple sclerosis and related disorders, Vol.46, pp.102540-102540

11/01/2020

DOI: https://doi.org/10.1016/j.msard.2020.102540

PMID: 33032060

Abstract

Clinical Neurology

Life Sciences & Biomedicine

Neurosciences & Neurology

Science & Technology

A long-term neurologic sequela arising from COVID-19 infection in multiple sclerosis (MS) patients could be related both to the increase of cytokines and the activation of NLRP3 inflammasome by the Sars-CoV2. These two mechanisms may cause a worsening of MS several months after the resolution of the infection.

Files and links (1)

url

https://doi.org/10.1016/j.msard.2020.102540View

Published (Version of record) Open

Metrics

1 Record Views

See more details

Details

Title: Could Sars-Cov2 affect MS progression?
Creators: Arianna Di Stadio - University of Perugia
Luigina Romani - University of Perugia
Evanthia Bernitsas - Wayne State University
Publication Details: Multiple sclerosis and related disorders, Vol.46, pp.102540-102540
Publisher: Elsevier
Number of pages: 2
Identifiers: 991006150045102656
Academic Unit: Neurology
Language: English
Resource Type: Journal article